<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Exp Med</journal-id><journal-title>The Journal of Experimental Medicine</journal-title><issn pub-type="ppub">0022-1007</issn><issn pub-type="epub">1540-9538</issn><publisher><publisher-name>The Rockefeller University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">10049949</article-id><article-id pub-id-type="pmc">2192950</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Lymph Node Germinal Centers Form in the Absence of Follicular Dendritic Cell Networks </article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Koni</surname><given-names>Pandelakis A.</given-names></name><xref ref-type="aff" rid="N0x41c8010N0x3e15c70">&#x0002a;</xref></contrib><contrib contrib-type="author"><name><surname>Flavell</surname><given-names>Richard A.</given-names></name><xref ref-type="aff" rid="N0x41c8010N0x3e15c70">&#x0002a;</xref><xref ref-type="aff" rid="N0x41c8010N0x3e15c70">&#x000a7;</xref></contrib></contrib-group><aff id="N0x41c8010N0x3e15c70">From the <label>&#x0002a;</label>Section of Immunobiology and <label>&#x000a7;</label>Howard Hughes Medical Institute, &#x02009;Yale University School  of Medicine, New Haven, Connecticut 06520-8011</aff><author-notes><fn><p>Address correspondence to Richard A. Flavell, Section of Immunobiology and Howard Hughes Medical  Institute, 310 Cedar St., FMB412, Yale University School of Medicine, New Haven, CT 06520-8011.  Phone: 203-737-2216; Fax: 203-785-7561; E-mail: <email>richard.flavell&#x00040;qm.yale.edu</email></p></fn></author-notes><pub-date pub-type="ppub"><day>1</day><month>3</month><year>1999</year></pub-date><volume>189</volume><issue>5</issue><fpage>855</fpage><lpage>864</lpage><history><date date-type="received"><day>1</day><month>12</month><year>1998</year></date><date date-type="rev-recd"><day>15</day><month>1</month><year>1999</year></date></history><copyright-year>1999</copyright-year><abstract><p>Follicular dendritic cell networks are said to be pivotal to both the formation of germinal centers (GCs) and their functions in generating antigen-specific antibody affinity maturation and B  cell memory. We report that lymphotoxin &#x003b2;&#x02013;deficient mice form GC cell clusters in the gross  anatomical location expected of GCs, despite the complete absence of follicular dendritic cell  networks. Furthermore, antigen-specific GC generation was at first relatively normal, but these  GCs then rapidly regressed and GC-phase antibody affinity maturation was reduced. Lymphotoxin &#x003b2;&#x02013;deficient mice also showed substantial B cell memory in their mesenteric lymph  nodes. This memory antibody response was of relatively low affinity for antigen at week 4 after  challenge, but by week 10 after challenge was comparable to wild-type, indicating that affinity  maturation had failed in the GC phase but developed later.</p></abstract><kwd-group><kwd>lymphotoxin &#x003b2;</kwd><kwd>knockout mice</kwd><kwd>follicular dendritic cells</kwd><kwd>germinal centers</kwd><kwd>B cell memory</kwd></kwd-group></article-meta></front><body><p>Follicular dendritic cells (FDCs)<sup>1</sup> are characterized by  their location within B cell follicles and their extensive  dendritic process networks, which retain antigen&#x02013;Ig complexes via both complement receptors and Ig Fc receptors  (for reviews, see references <xref ref-type="bibr" rid="B1">1</xref>&#x02013;<xref ref-type="bibr" rid="B4">4</xref>). Some antigen retained by  FDCs is held within convolutions of the dendritic process  network for periods of &#x0003e;1 yr and is thought to play an important role in the maintenance of long-term B cell memory. It is perhaps these same processes that have gained  FDCs notoriety as a reservoir of HIV (<xref ref-type="bibr" rid="B5">5</xref>&#x02013;<xref ref-type="bibr" rid="B8">8</xref>).</p><p>FDCs also give up some of their retained antigen much  earlier, during the germinal center (GC) reaction. GCs are  highly specialized structures that develop within primary B  cell follicles upon antigenic challenge (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). Antigen-specific B cells within GCs undergo somatic hypermutation of  their antigen-binding receptor in a process of antibody affinity maturation (<xref ref-type="bibr" rid="B9">9</xref>&#x02013;<xref ref-type="bibr" rid="B11">11</xref>). GC B cells are intimately associated with FDC dendritic processes, and antigen provided  by FDC networks is thought to be critical for the selection  of higher affinity clones within GCs and subsequent memory B cell formation (<xref ref-type="bibr" rid="B1">1</xref>&#x02013;<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B12">12</xref>). FDCs also provide other  soluble and contact-dependent signals which promote GC  B cell viability, proliferation, and chemotactic responsiveness (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B13">13</xref>). It has also been asserted that FDCs may be the  &#x0201c;nucleating force&#x0201d; for the initial formation of GCs within  the specific anatomical location they occupy (<xref ref-type="bibr" rid="B4">4</xref>).</p><p>Lymphotoxin (LT)&#x003b2; is an immediate member of the TNF  family, first identified by virtue of its ability to anchor LT&#x003b1;  (TNF-&#x003b2;) to the surface of T cell hybridomas (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). Both  LT&#x003b1; and LT&#x003b2; are now known to be produced by activated  B cells, activated T cells, and NK cells (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>). Effects of  LT&#x003b2;R engagement include integrin upregulation (<xref ref-type="bibr" rid="B18">18</xref>), cytotoxicity (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>), and induction of chemokine production  (<xref ref-type="bibr" rid="B21">21</xref>). Most notably, <italic>lt&#x003b1;</italic><sup>&#x02212;/&#x02212;</sup> mice, <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice, and <italic>lt&#x003b2;r</italic><sup>&#x02212;/&#x02212;</sup>  mice lack peripheral LNs and Peyer's patches, and have a  disorganized splenic architecture with almost complete loss  of GCs and FDC networks (<xref ref-type="bibr" rid="B22">22</xref>&#x02013;<xref ref-type="bibr" rid="B29">29</xref>). Having said this, most  <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice still have mesenteric (M)LNs (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B30">30</xref>). Furthermore, the MLNs still form GC-like cell clusters in rudimentary B cell follicles despite the apparent lack of FDC networks (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B30">30</xref>). Similar observations have been made in the  spleen of <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice and <italic>lt&#x003b2;r</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="bibr" rid="B27">27</xref>&#x02013;<xref ref-type="bibr" rid="B29">29</xref>), although  these studies also found residual FDC-like cells. Although  not yet proven, the latter may be FDC precursors or immature FDCs but equally so might represent GC dendritic cells  (GCDCs), which are distinct from FDCs and have so far  been described in human tonsils (<xref ref-type="bibr" rid="B31">31</xref>) but not in mice.</p><p>Therefore, <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse MLNs appeared to present a  unique model of in vivo GC reaction in the absence of FDC  networks. Although other studies have suggested that GCs can  form in the absence of antigen trapping on FDCs (<xref ref-type="bibr" rid="B32">32</xref>), an  FDC-less mouse model was unprecedented and would further  studies of GC reaction. <italic>Lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice might also facilitate the  identification and evaluation of GCDCs. Finally, knowledge  of the consequences of a lack of FDC networks will also be essential in assessing the potential utility of causing FDC regression. That is, it was recently reported that administration of  soluble LT&#x003b2;R to adult mice results in temporary regression of  FDC networks (<xref ref-type="bibr" rid="B33">33</xref>). Thus, there is now the prospect of being  able to eliminate FDC networks in circumstances in which  this might be considered likely to yield therapeutic benefit.  For example, loss of FDC networks during triple drug therapy  might eliminate this important HIV reservoir.</p><p>With all of this in mind, this study reports the dynamics of  GC reaction and B cell memory formation in <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice.  Initiation of antigen-specific GCs in the MLNs of <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup>  mice was relatively normal, but GC B cell numbers subsequently fell dramatically. GC B cells were clustered in the  anatomical locations expected of GCs, indicating that this  process is not critically dependent on FDC networks. <italic>Lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup>  mice also generated substantial B cell memory despite defective GC processes, albeit of relatively low affinity. Some antigen-specific antibody affinity maturation did occur and was  even more apparent in the memory response, suggesting that  somatic hypermutation had occurred. This is in agreement  with other studies where somatic hypermutation was evident, even in the complete absence of GCs (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B34">34</xref>).</p><sec id="MaterialsMethods" sec-type="materials|methods"><title>Materials and Methods</title><sec disp-level="3"><title>Reagents.</title><p>The protein G&#x02013;Sepharose column&#x02013;purified antibodies anti&#x02013;&#x003bb;1 L chain (Ls136) and FDC-M2 were provided by Garnett  Kelsoe (Duke University, Durham, NC) and Marie  Kosco-Vilbois  (Serono Pharmaceutical Research Institute, Geneva, Switzerland),  respectively. Both were conjugated using a biotin coupling reagent  (<named-content content-type="company" xlink:href="boehringer">Boehringer Mannheim</named-content>) at a biotin/antibody molar ratio of 10:1 and  purified on a Sephadex G-25 column (<named-content content-type="company" xlink:href="boehringer">Boehringer Mannheim</named-content>). Rat  anti&#x02013;mouse IgD and anti&#x02013;mouse CD11b (Mac-1) from <named-content content-type="company" xlink:href="pharmingen">PharMingen</named-content>  were also coupled as above but with digoxigenin (DIG) rather than  biotin, also from <named-content content-type="company" xlink:href="boehringer">Boehringer Mannheim</named-content>.</p><p>Chicken &#x003b3;-globulin (CG; <named-content content-type="company" xlink:href="sigma">Sigma</named-content>) was conjugated with  (4-hydroxy-3-nitrophenyl)acetyl (NP) succinimide ester (<named-content content-type="company" xlink:href="calbiochem">Calbiochem</named-content>) in 0.1 M sodium borate, pH 9.2, to a NP/CG molar ratio  of 13:1 (NP<sub>13</sub>CG) and then dialyzed against PBS. PE (Molecular  Probes) was haptenated in the same fashion but in the dark at a  molar ratio of 20:1 to generate NP<sub>20</sub>PE. BSA was also haptenated  to create NP<sub>2</sub>BSA and NP<sub>15</sub>BSA. The precise degree of haptenation was not determined.</p></sec><sec disp-level="3"><title>Animals and Animal Challenge.</title><p><italic>Cd40l</italic><sup>&#x02212;/&#x02212;</sup> mice and <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice  are those described previously (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B35">35</xref>). Wild-type control mice were  derived from original wild-type littermates of <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="bibr" rid="B26">26</xref>).  <italic>Tcr(&#x003b2;&#x000d7;&#x003b4;)</italic><sup>&#x02212;/&#x02212;</sup> mice were generated from breeding pairs originally  purchased from The <named-content content-type="company" xlink:href="jackson">Jackson Laboratory</named-content>. All mice are on a mixed  background of C57BL/6 and 129/Sv and were housed in specific  pathogen&#x02013;free conditions. All experiments were conducted in accordance with Yale University Animal Care and Use guidelines.</p><p>Mice at 6&#x02013;8 wk of age were challenged intraperitoneally with  50 &#x003bc;g of either CG or NP<sub>13</sub>CG, both of which were adsorbed to  alum in 0.1 ml PBS. Some mice at various times may have received a second challenge of 200 &#x003bc;g NP<sub>13</sub>CG in 0.1 ml PBS alone.</p><p>Hyperimmunized mouse serum for the purpose of anti-NP antibody standardization (see below) was obtained from wild-type  mice 6 d after being boosted with 0.2 mg NP<sub>13</sub>CG in PBS, 27 d after the primary challenge with 50 &#x003bc;g NP<sub>13</sub>CG adsorbed to alum.</p></sec><sec disp-level="3"><title>MLN Histology.</title><p>MLNs were frozen in Tissue-Tek OCT  compound (VWR Scientific) using a dry-ice/methylbutane bath  and stored at &#x02212;70&#x000b0;C until cutting. Sections of 5-&#x003bc;m thickness  were cut onto silanized glass slides, fixed in cold acetone for 10  min, air-dried, and then stored at &#x02212;70&#x000b0;C until use. For staining,  sections were thawed for 30 min and then rehydrated in PBS for  20 min. Endogenous peroxidase was quenched with 0.3% hydrogen peroxide for 5 min. Sections were washed in PBS for 10 min  and then preblocked with PBS/3% BSA/0.1% Tween 20 for 30  min in a humidified chamber. Staining for IgD was with rat anti-IgD (Southern Biotechnology Associates) and then horseradish  peroxidase&#x02013;conjugated goat anti&#x02013;rat IgG (Southern Biotechnology Associates). The presence of FDCs was assessed with biotin-conjugated FDC-M2 (see Reagents). Other biotin-conjugated  antibodies were anti-CD23 and anti-CD24, both from <named-content content-type="company" xlink:href="pharmingen">PharMingen</named-content>. All biotin conjugates used a secondary step of alkaline phosphatase&#x02013;conjugated streptavidin (<named-content content-type="company" xlink:href="zymed">Zymed)</named-content>. Incubations were in a  humidified chamber for 1 h. Washes between steps were with  PBS/0.1% Tween 20. Substrates for horseradish peroxidase and  alkaline phosphatase were diaminobenzidine (brown) and NBT/ BCIP (purple-blue), respectively (<named-content content-type="company" xlink:href="zymed">Zymed)</named-content>. Counter-staining was  with nuclear fast red (<named-content content-type="company" xlink:href="zymed">Zymed)</named-content>.</p></sec><sec disp-level="3"><title>MLN Cell Preparation.</title><p>MLNs were harvested into 0.5 ml  cold digest buffer in a 4-well plate (Nunc) on ice. Digest buffer  was Bruff's medium with 5% FCS, 0.1 mg/ml collagenase type  IV (<named-content content-type="company" xlink:href="sigma">Sigma</named-content>), and 0.1 mg/ml deoxyribonuclease type I (<named-content content-type="company" xlink:href="sigma">Sigma</named-content>).  Bruff's medium is Click's medium (Irvine Scientific) supplemented with 40 mM <sc>l</sc>-glutamine, 60 &#x003bc;M 2-ME, 0.7 mM sodium bicarbonate, and 58 mg/l gentamycin. The capsule of each  MLN was torn and teased open with 27-gauge needles before  incubating plates at 37&#x000b0;C for 30 min. Capsules were then further  disrupted to release MLN cells by pipetting. The cell suspension was  made up to 10 ml with Bruff's/5% FCS, filtered through 0.1-mm  nylon mesh (Small Parts, Inc.), and centrifuged at 800 revolutions/min in a bench-top centrifuge at 4&#x000b0;C for 5 min. Finally,  cells were resuspended in 2 ml Bruff's/5% FCS for fluorocytometry or antigen-specific antibody determination as described below.</p></sec><sec disp-level="3"><title>Fluorocytometry.</title><p>MLN cells were prepared as described above,  and aliquots of 10<sup>6</sup> cells were resuspended into 0.2 ml PBS/1%  FCS supplemented with 5 &#x003bc;g/ml FcBlock (<named-content content-type="company" xlink:href="pharmingen">PharMingen</named-content>). Samples were left on ice for 30 min before primary antibodies were  added, and were then left on ice in the dark for an additional 1 h.  Samples were washed by being made up to 1.2 ml with PBS/1%  FCS before centrifugation at 800 revolutions/min at 4&#x000b0;C for 5  min. Secondary antibody incubation and rewashing were done as  above. Four-color fluorocytometry used a FACSCalibur<sup>&#x000ae;</sup> with  argon and helium-neon lasers (<named-content content-type="company" xlink:href="becton">Becton Dickinson</named-content>). Data from 2.5 &#x000d7;  10<sup>5</sup> events were analyzed with CellQuest software by first gating  on lymphocytes/lymphoblasts, based on forward and side scatter.  <named-content content-type="company" xlink:href="pharmingen">PharMingen</named-content> antibodies used included anti-CD4&#x02013;allophycocyanin  (APC; L3T4, RM4-5), anti-CD8&#x003b1;&#x02013;APC (53-6.7), anti-CD90.2&#x02013; APC (53-2.1), GL7-FITC, anti-CD45R&#x02013;FITC, anti-CD24&#x02013;biotin  (M1/69), and anti-CD45R&#x02013;biotin. Peanut agglutinin (PNA)- biotin, streptavidin&#x02013;Cy-Chrome, and anti-digoxin&#x02013;Cy5 were  from Vector, <named-content content-type="company" xlink:href="pharmingen">PharMingen</named-content>, and <named-content content-type="company" xlink:href="jackson">Jackson Laboratories</named-content>, respectively. Other reagents used were anti-&#x003bb;1&#x02013;biotin, anti-IgD&#x02013;DIG,  and anti-CD11b&#x02013;DIG, described in Reagents above.</p></sec><sec disp-level="3"><title>MLN Antigen-specific Antibody Determination.</title><p> Antigen-specific antibody determination was done essentially as described by  Kelly et al. (<xref ref-type="bibr" rid="B36">36</xref>), using antibody-secreting cells directly in an  ELISA. Maxisorp 96-well plates (Nunc) were coated at 4&#x000b0;C for  16&#x02013;20 h with 10 &#x003bc;g/ml NP<sub>2</sub>BSA or NP<sub>15</sub>BSA in PBS, 0.1 ml aliquot per well. Plates were then washed four times with PBS before blocking with PBS/1% FCS for 2&#x02013;3 h. Meanwhile, MLN  cells were prepared at 10<sup>7</sup> cells per ml of Bruff's/5% FCS as described above. MLN cell aliquots of 0.1 ml were then plated in  wells and cultured at 37&#x000b0;C for 5 h alongside a twofold serial dilution of serum from a standard hyperimmunized wild-type mouse  (see above; serum dilution was with PBS/1% FCS). Subsequent  washes were with PBS/0.05% Tween 20. Ig detection used isotype-specific alkaline phosphatase&#x02013;conjugated reagents and pNPP  substrate as described (Southern Biotechnology Associates). OD<sub>405  </sub>was determined with a microplate reader (model 550; BioRad).  Typically, a 1:12,800 dilution of hyperimmunized wild-type mouse  serum gave an OD<sub>405</sub> of &#x0223c;2.7 and 1.9 above background for IgG1  detected with NP<sub>2</sub>BSA and NP<sub>15</sub>BSA, respectively. The lower limit  of detection was typically at a serum dilution of 1:1,638,400, giving  an OD<sub>405</sub> of &#x0223c;0.05&#x02013;0.10 above background. The anti-NP&#x02013;specific  antibody titer of samples was expressed as relative units, representing  the reciprocal of the standard serum dilution giving the same OD<sub>405</sub>  as the sample. Calculations were by four-parameter analysis using  Microplate Manager III software (BioRad).</p></sec><sec disp-level="3"><title>Serum Antigen-specific Antibody Determination.</title><p>Blood was harvested from mice for serum by cardiac puncture at the time of  culling. Maxisorp plates were coated with NP<sub>2</sub>BSA or NP<sub>15</sub>BSA,  blocked, and washed as described above. Serum aliquots of 0.1 ml  (1:10<sup>5</sup> in PBS/1% FCS) were applied to wells for 1 h alongside a  twofold serial dilution of serum from a hyperimmunized wild-type mouse (see above; serum dilution was with PBS/1% FCS).  Antigen-specific Ig determination then proceeded as described in  the previous section.</p></sec></sec><sec id="Results"><title>Results</title><sec disp-level="4"><title>Lt&#x003b2;<sup>&#x02212;</sup><sup>/&#x02212;</sup> Mice Form GC B Cell Clusters but Lack FDCs.</title><p>We showed previously that <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice form PNA-binding, IgD<sup>&#x02212;</sup>B220<sup>&#x0002b;</sup> cell clusters in B cell areas of their MLNs  (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B30">30</xref>), characteristic of GCs (<xref ref-type="bibr" rid="B37">37</xref>). Although IgD<sup>&#x0002b;</sup> B cells  were also found to infiltrate T cell areas, the GC-like B cell  clusters were within IgD<sup>&#x0002b;</sup> B cell follicles at the periphery of  MLNs, as in wild-type mouse MLNs (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B30">30</xref>). These observations were extended here by staining for CD24. Primary follicle B cells are CD24<sup>&#x0002b;</sup>, but GC B cells are CD24<sup>hi</sup>  (38&#x02013;40; Fig. <xref ref-type="fig" rid="F1">1</xref> A). This also appeared to be true of <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup>  GC B cell clusters (Fig. <xref ref-type="fig" rid="F1">1</xref> B). Again, the <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> GC B cells  were clustered within the location expected of wild-type GCs. </p><p>Immunohistology with anti&#x02013;complement receptor 1 (CR-1)  and FDC-M1 suggested that <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice lack FDCs (<xref ref-type="bibr" rid="B26">26</xref>).  We subsequently showed that although wild-type mouse  MLNs have very large amounts of IgM immune complex  on FDCs, <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse MLNs did not have any such deposits (<xref ref-type="bibr" rid="B30">30</xref>). However, despite all of the above, it is possible  that Ig Fc receptor&#x02013;bearing (FcR<sup>&#x0002b;</sup>) FDCs (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B9">9</xref>) constitute a distinct subset of FDCs which are negative for both  FDC-M1 and CR-1. It is also conceivable that antigen&#x02013;Ig  complexes retained on such FcR<sup>&#x0002b;</sup> FDCs may support GC  reaction in the absence of CR-1<sup>&#x0002b;</sup> FDCs. In potential support of this, mice deficient in CR-1 still possess GCs (<xref ref-type="bibr" rid="B41">41</xref>,  <xref ref-type="bibr" rid="B42">42</xref>), albeit somewhat smaller than wild-type.</p><p>Therefore, an evaluation was made as to whether or not  <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice possess FcR<sup>&#x0002b;</sup> FDC networks by staining for  CD23 (<xref ref-type="bibr" rid="B43">43</xref>). This revealed that <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice completely lack  FcR<sup>&#x0002b;</sup> FDC networks (Fig. <xref ref-type="fig" rid="F1">1</xref> D), and that the <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> GC B  cell clusters were CD23<sup>&#x02212;</sup> compared with the surrounding  follicle B cells, as expected of wild-type GC B cells (9; Fig.  <xref ref-type="fig" rid="F1">1</xref> C). FDC networks clearly stained very strongly for CD23  in wild-type mouse MLNs (Fig. <xref ref-type="fig" rid="F1">1</xref> C), and were observed  in every B cell follicle regardless of whether or not there  was an ongoing GC reaction. Some discrete CD23<sup>lo</sup> cells  were seen in the <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse MLN CD23<sup>&#x02212;</sup>IgD<sup>&#x02212;</sup> GC cell  clusters (Fig. <xref ref-type="fig" rid="F1">1</xref> D). These cells most likely represent GC B  cells that have not yet fully downregulated CD23, but it is  conceivable that they represent immature FDCs or the  mouse equivalent of GCDCs (<xref ref-type="bibr" rid="B31">31</xref>).</p><p>Finally, the lack of staining by FDC-M2 further emphasized the complete absence of FDC networks in the MLNs  of <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice (Fig. <xref ref-type="fig" rid="F1">1</xref> F). Although FDC-M2 has not been  fully characterized, it is a useful marker of FDC networks  (Fig. <xref ref-type="fig" rid="F1">1</xref> E). Like CD23, FDC-M2 staining was observed in  every wild-type mouse MLN B cell follicle regardless of  whether or not there was an ongoing GC reaction (data  not shown). As with CD23, a low level of FDC-M2 staining may well mark immature FDCs or another cell type  such as the mouse equivalent of GCDCs (<xref ref-type="bibr" rid="B31">31</xref>). Neither immature FDCs nor mouse GCDCs have yet been defined.</p></sec><sec disp-level="4"><title>Lt&#x003b2;<sup>&#x02212;</sup><sup>/&#x02212;</sup> Mice Show Increased GC B Cells upon Intraperitoneal Challenge.</title><p>Four-color fluorocytometry was adopted  in order to study further the GC reaction in <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse  MLNs (see Materials and Methods). Most non-GC B cells  were excluded as &#x0201c;lineage&#x0201d;-positive (Lin<sup>&#x0002b;</sup>) cells, using a  combination of antibodies against CD4, CD8&#x003b1;, CD90.2,  IgD, and CD11b (Fig. <xref ref-type="fig" rid="F2">2</xref>). Markers to discriminate GC B  cells included PNA binding (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B38">38</xref>), anti-CD24 (<xref ref-type="bibr" rid="B38">38</xref>&#x02013;<xref ref-type="bibr" rid="B40">40</xref>),  and GL7 (<xref ref-type="bibr" rid="B44">44</xref>). PNA binding and CD24 are increased on  GC B cells, whereas GL7 recognizes an activation antigen  found on GC B cells but not naive or memory B cells. Fluorocytometry of MLNs is simple compared with spleen  due to the relative lack of immature B cells, granuloid cells,  and erythroid cells. After excluding nonlymphoid particles  of low forward scatter (data not shown), most Lin<sup>&#x02212;</sup> cells in  MLNs are PNA<sup>hi</sup>CD24<sup>hi</sup> (data not shown). This is demonstrated in Fig. <xref ref-type="fig" rid="F2">2</xref> with MLNs 12 d after intraperitoneal challenge with CG adsorbed to alum. </p><p>As expected, both T cell&#x02013;less mice and <italic>cd40l</italic><sup>&#x02212;/&#x02212;</sup> mice fail  to generate GC B cells (Fig. <xref ref-type="fig" rid="F2">2</xref>), most clearly demonstrated  with GL7. Both wild-type mice and <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice revealed  substantial levels of Lin<sup>&#x02212;</sup>GL7<sup>&#x0002b;</sup> cells in their MLNs, although <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice consistently had lower levels than  wild-type mice (see also below). Lin<sup>&#x02212;</sup>GL7<sup>&#x0002b;</sup> cells represented about half of all Lin<sup>&#x02212;</sup>PNA<sup>hi</sup>CD24<sup>hi</sup> cells (Fig. <xref ref-type="fig" rid="F2">2</xref>) and  were CD45R<sup>&#x0002b;</sup> (data not shown; see below). Lin<sup>&#x02212;</sup> cells include non-GC B cells such as antibody-secreting cells and  memory B cells, which would be GL7<sup>&#x02212;</sup>.</p><p>The levels of Lin<sup>&#x02212;</sup>GL7<sup>&#x0002b;</sup> GC B cells at day 12 after challenge (Fig. <xref ref-type="fig" rid="F2">2</xref>) were much higher than those in unchallenged mice, and were similar to those observed in the  spleen with the same antigenic challenge (<xref ref-type="bibr" rid="B45">45</xref>). Without intraperitoneal challenge, the levels of Lin<sup>&#x02212;</sup>GL7<sup>&#x0002b;</sup> cells were  0.3&#x02013;0.7% of total MLN cells in both wild-type mice and  <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice (data not shown; see below), consistent with  levels in the spleen of unchallenged wild-type mice (<xref ref-type="bibr" rid="B45">45</xref>).  Thus, intraperitoneal challenge in alum is an effective  means of inducing GC B cell generation in the MLNs of  both wild-type mice and <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice.</p></sec><sec disp-level="4"><title>Lt&#x003b2;<sup>&#x02212;</sup><sup>/&#x02212;</sup> Mice Generate Antigen-specific GC B Cells.</title><p> The  hapten NP has been used extensively in GC studies (40, 45&#x02013; 48). The primary response to NP is dominated by antibodies  bearing a &#x003bb;1 light chain, recognized by the antiidiotype antibody Ls136 (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B49">49</xref>&#x02013;<xref ref-type="bibr" rid="B52">52</xref>). NP-specific antibody-bearing cells  can also be followed by their capacity to bind NP-conjugated  PE (NP<sub>20</sub>PE). NP also provides a means for evaluating anti-NP&#x02013;specific antibody affinity maturation (described below).</p><p>Mice were challenged intraperitoneally with either CG  or NP-haptenated CG (NP<sub>13</sub>CG), and MLNs were examined for NP-specific response 8 d later. Both wild-type mice and <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice showed massive numbers of &#x003bb;1<sup>&#x0002b;</sup>  NP<sub>20</sub>PE-binding MLN cells in response to NP<sub>13</sub>CG  (Fig. <xref ref-type="fig" rid="F3">3</xref>). The percentage of CD45R<sup>&#x0002b;</sup> cells that were &#x003bb;1<sup>&#x0002b;</sup>  NP<sub>20</sub>PE-binding were 66.1 &#x000b1; 18.2 and 76.6 &#x000b1; 17.2 for  wild-type mouse MLNs and <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse MLNs, respectively (<italic>n</italic> &#x0003d; 6 each), compared with &#x0003c;0.1% in unchallenged  mice. As expected (<xref ref-type="bibr" rid="B46">46</xref>), CG itself did not elicit any significant levels of &#x003bb;1<sup>&#x0002b;</sup> NP<sub>20</sub>PE-binding cells (data not shown).  Also, T cell&#x02013;less mice and <italic>cd40l</italic><sup>&#x02212;/&#x02212;</sup> mice did not show significant levels of &#x003bb;1<sup>&#x0002b;</sup> NP<sub>20</sub>PE-binding cells (Fig. <xref ref-type="fig" rid="F3">3</xref>). </p><p>NP-specific GC B cells were also evident in MLNs from  both wild-type mice and <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice at day 8 after challenge (Fig. <xref ref-type="fig" rid="F4">4</xref>), defined as the Lin<sup>&#x02212;</sup>GL7<sup>&#x0002b;</sup> subset (see Fig. <xref ref-type="fig" rid="F2">2</xref>).  Both the fraction of <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> GC B cells that were NP<sub>20</sub>PE-binding and the intensity of NP<sub>20</sub>PE-binding appeared to  be relatively normal (Fig. <xref ref-type="fig" rid="F4">4</xref>). The response of wild-type  mice and <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice was then followed from day 8 to day  24 after challenge (Fig. <xref ref-type="fig" rid="F5">5</xref>). As early as day 12 after challenge, <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse MLN &#x003bb;1<sup>&#x0002b;</sup> GC B cells were greatly  reduced compared with wild-type, and even fewer were  NP<sub>20</sub>PE-binders (Fig. <xref ref-type="fig" rid="F5">5</xref>). Having said this, the rate of decline of <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> GC B cells was not sustained at day 16 after  challenge. Instead, Lin<sup>&#x02212;</sup>GL7<sup>&#x0002b;</sup>&#x003bb;1<sup>&#x0002b;</sup> <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> GC B cell levels  appeared to plateau such that they were comparable to  wild-type at day 20 after challenge before then falling again  by day 24 (Fig. <xref ref-type="fig" rid="F5">5</xref>). This pattern was reflected among  Lin<sup>&#x02212;</sup>GL7<sup>&#x02212;</sup>&#x003bb;1<sup>&#x0002b;</sup> non-GC cells.  </p></sec><sec disp-level="4"><title>Lt&#x003b2;<sup>&#x02212;</sup><sup>/&#x02212;</sup> Mice Generate Antigen-specific Memory B  Cells.</title><p>Both  <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice and wild-type mice showed anti-NP antibody secretion among MLN cells at day 6 after challenge with 50 &#x003bc;g  NP<sub>13</sub>CG adsorbed to alum (Fig. <xref ref-type="fig" rid="F6">6</xref>). IgA and IgG2a were not  detected at all (data not shown). Clearly, IgG1 secretion by  <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse MLN cells (average relative units &#x0003d; 0.91) was  much lower than wild-type (average &#x0003d; 6.03), perhaps indicating a lack of T cell and/or dendritic cell help. Nonetheless, this  level of IgG1 secretion by <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse MLNs was &#x0223c;20-fold  higher than the lower limit of detection. Also, a primary challenge with 0.2 mg NP<sub>13</sub>CG in PBS alone did not result in significant anti-NP antibody secretion by either wild-type or  <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse MLN cells at day 6 after challenge (data not  shown). Thus, the response to NP<sub>13</sub>CG in PBS was a good indicator of memory generated as a result of primary challenge  with NP<sub>13</sub>CG adsorbed to alum (see below). </p><p>To determine whether or not humoral memory was  generated, mice were challenged as before and then rechallenged at various times with either 0.2 mg NP<sub>13</sub>CG in PBS  without alum or PBS alone. 6 d later, anti-NP antibody  was determined among MLN cells and in serum. Both the  level of anti-NP antibody and the relative affinity for NP  were determined by ELISA using two different BSA substrates. Total and relatively high affinity anti-NP antibody  were determined with densely (NP<sub>15</sub>BSA) and sparsely  (NP<sub>2</sub>BSA) haptenated BSA, respectively. As GC reaction  proceeds, a greater proportion of anti-NP antibody becomes  detectable with NP<sub>2</sub>BSA. The principal of this approach has  been used in several other studies (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B34">34</xref>), and was recently validated with mAbs of various affinity for NP (<xref ref-type="bibr" rid="B45">45</xref>).</p><p>When given a secondary challenge and harvested at week  4, <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse MLNs appeared to secrete more anti-NP  antibody than wild-type mouse MLNs (Fig. <xref ref-type="fig" rid="F7">7</xref>), implying  that <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice had generated greater humoral memory  than wild-type mice. This pattern was not so apparent in serum (Fig. <xref ref-type="fig" rid="F7">7</xref>). Nonetheless, <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice clearly showed memory even in their serum. The substantial memory response  was still evident among <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse MLNs at week 10 after challenge but was less evident in serum (Fig. <xref ref-type="fig" rid="F7">7</xref>). </p><p>Both wild-type mouse MLNs and <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse MLNs  showed affinity maturation in the post-GC phase between  weeks 4 and 10 after challenge (Fig. <xref ref-type="fig" rid="F7">7</xref>). Thus, the relatively  low NP<sub>2</sub>/NP<sub>15</sub> ratio in <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse MLNs at week 4 after  challenge was almost normal at week 10. Again, this observation in MLNs was not obvious in serum (Fig. <xref ref-type="fig" rid="F7">7</xref>). At both  weeks 4 and 10 after challenge, <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice showed a  lower NP<sub>2</sub>/NP<sub>15</sub> ratio in their serum than wild-type mice,  indicating a defect in GC affinity maturation processes.</p></sec></sec><sec id="Discussion"><title>Discussion</title><p>Numerous lines of evidence have now shown that <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup>  mice do not have FDC networks (26, 27, 30, and this  study). In addition, MacKay and Browning (<xref ref-type="bibr" rid="B33">33</xref>) have very  recently shown that administration of soluble LT&#x003b2;R to  adult mice causes regression of FDC networks and dissipation of the antigen they were retaining. Clearly however,  <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice might still have FDC precursors. Indeed, irradiated adult <italic>lt&#x003b1;</italic><sup>&#x02212;/&#x02212;</sup> mice generate mature FDC networks of  <italic>lt&#x003b1;</italic><sup>&#x02212;/&#x02212;</sup> origin upon reconstitution with wild-type bone  marrow (<xref ref-type="bibr" rid="B53">53</xref>), and equivalent results have been obtained  with <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice (data not shown). The location of FDC  precursors in <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice is at present unknown, and it is  conceivable that they will be found within B cell follicles  and GCs even though they fail to develop into mature  FDC networks. Others have shown that <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice and  <italic>lt&#x003b2;r</italic><sup>&#x02212;/&#x02212;</sup> mice do have small numbers of discrete FDC-M2<sup>&#x0002b;</sup>  cells in the spleen (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>), leading to the suggestion that  these cells may represent FDC precursors or immature  FDCs. However, there is no evidence that FDC-M2 is completely specific to FDCs, although it is a useful marker of  FDC networks. Unlike FDC-M2, FDC-M1 has been well  characterized and is considered to be relatively FDC specific,  but even this marker also stains tingible body macrophages  (which are found in GCs) and some endothelial cells (<xref ref-type="bibr" rid="B54">54</xref>).</p><p>The origin of FDCs is somewhat controversial (for a review, see reference <xref ref-type="bibr" rid="B55">55</xref>) and will undoubtedly be further  complicated by the fact that mice may also prove to have  GCDCs (<xref ref-type="bibr" rid="B31">31</xref>), which might be the FDC-M2<sup>&#x0002b;</sup> cells seen by  others. Regardless of whether or not <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice have  FDC precursors, the roles FDCs are said to fulfill largely  rely on the extensive dendritic processes of FDC networks.  Clearly, these structures are absent.</p><p>The absence of FDC networks presumably has indirect  as well as direct effects on GC reactions. For example, this  study has not considered GC T cells in <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice. Other  defects clearly exist in <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse MLNs, such as the B  cell infiltration of the T cell areas and reduced primary humoral response. What this study has attempted to do is  highlight the processes that occur despite the defects. Most  notably, <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice generate antigen-specific GC B cells  and class-switched memory B cell responses. Having said  this, antigen-specific <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> GC B cells decline rapidly at  times when wild-type GC B cell numbers are still relatively  high. GCs normally have a life span of a few weeks (<xref ref-type="bibr" rid="B10">10</xref>,  <xref ref-type="bibr" rid="B56">56</xref>). It has been argued that the regression of GCs begins at  a time when FDCs begin to bury their retained antigen  within membrane pockets, thereby ceasing to present antigen to GC B cells (<xref ref-type="bibr" rid="B56">56</xref>). The decline of <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> GC B cells in  the absence of FDC networks may be a premature execution of this process. On the other hand, <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> GC B cell  numbers did not decline further between days 12 and 16  after challenge but instead appeared to plateau until they finally decreased further between days 20 and 24. It is conceivable that the Lin<sup>&#x02212;</sup>GL7<sup>&#x0002b;</sup>&#x003bb;1<sup>&#x0002b;</sup> cell numbers were maintained by further generation of such cells from centroblasts.</p><p>Anti-NP memory and relative affinity maturation were  assessed at various times. The humoral memory response in  <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse MLNs was as great if not greater than that  seen in wild-type mouse MLNs (Fig. <xref ref-type="fig" rid="F7">7</xref>). Of course, this  may not be a direct reflection of the actual frequency of  NP-specific memory B cells. The relatively low level of  NP-specific non-GC B cells (Lin<sup>&#x02212;</sup>&#x003bb;1<sup>&#x0002b;</sup> NP<sub>20</sub>PE-binding) in  <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse MLNs late in the GC phase (Fig. <xref ref-type="fig" rid="F5">5</xref>) suggests  that <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse MLNs produce significantly fewer memory B cells than wild-type mouse MLNs.</p><p>The degree of affinity maturation observed in serum  here was similar to that previously reported for <italic>lt&#x003b1;</italic><sup>&#x02212;/&#x02212;</sup>  mice, Lyn kinase (<italic>lyn</italic>)<sup>&#x02212;/&#x02212;</sup> mice, and <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B26">26</xref>,  <xref ref-type="bibr" rid="B34">34</xref>). Affinity maturation requires somatic hypermutation  and subsequent selection of higher affinity clones, suggesting that specific activated B cells had entered into a &#x0201c;GC B  cell program&#x0201d; despite the complete absence of GCs in <italic>lt&#x003b1;</italic><sup>&#x02212;/&#x02212;</sup>  mice and <italic>lyn</italic><sup>&#x02212;/&#x02212;</sup> mice. Indeed, somatic hypermutation is  evident in <italic>lt&#x003b1;</italic><sup>&#x02212;/&#x02212;</sup> mice and <italic>lyn</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B34">34</xref>), and there  is no reason to believe that this is not occurring in <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup>  mice. Certainly, somatic hypermutation is normally evident as early as day 7 after challenge (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>)  and, unlike <italic>lt&#x003b1;</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="bibr" rid="B24">24</xref>) and <italic>lyn</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="bibr" rid="B34">34</xref>), <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup>  mice generate appreciable levels of antigen-specific GC B  cells upon challenge (this study).</p><p>Where and how are high-affinity mutants selected in the  absence of GCs? Takahashi et al. (<xref ref-type="bibr" rid="B45">45</xref>) recently described  evidence in support of a phenomenon best described as  &#x0201c;post-GC intraclonal competition.&#x0201d; The average affinity of  anti-NP antibody from bone marrow antibody-secreting  cells continued to increased long after the GC reaction had  waned (<xref ref-type="bibr" rid="B45">45</xref>). Although clonal selection occurs independently in each GC and low-affinity B cells can survive the  selection process within GCs if high-affinity competitors  are absent (<xref ref-type="bibr" rid="B45">45</xref>), post-GC affinity-driven selection processes  effectively constitute &#x0201c;inter-GC selection.&#x0201d; This concept is  supported by the study here, where the relative affinity of  anti-NP antibody at week 10 after challenge was about  twofold higher than that at week 4 after challenge (Fig. <xref ref-type="fig" rid="F7">7</xref>),  in the MLNs of wild-type mice and <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice.</p><p>Thus, mutants with higher affinity for the antigen are  generated and selected even in <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice, but the highest  possible affinity for antigen is not achieved in <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice  (Fig. <xref ref-type="fig" rid="F7">7</xref>), presumably because further rounds of somatic mutation cannot occur in the post-GC phase. Hence, despite  post-GC intraclonal competition, the benefit of the GCs is  as an environment in which repeated rounds of somatic  mutation and selection can occur rapidly in order to  achieve the highest possible affinity for antigen. Indeed, although substantial somatic hypermutation was observed in  <italic>lt&#x003b1;</italic><sup>&#x02212;/&#x02212;</sup> mice, the degree of mutation among V186.2 genes  was only about half that seen in wild-type mice (<xref ref-type="bibr" rid="B24">24</xref>).</p><p>It should also be borne in mind that the apparent degree  of affinity maturation by post-GC intraclonal competition  will vary substantially depending on the nature of the antigen. In some experimental instances, random mutations lead  to higher affinity clones at a relatively high frequency (<xref ref-type="bibr" rid="B59">59</xref>).  The NP hapten used here and by others (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B45">45</xref>) would  appear to be another such example, since a frequently occurring single point mutation in the V186.2 gene (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B60">60</xref>) is associated with greatly increased affinity for NP (<xref ref-type="bibr" rid="B61">61</xref>). Thus, the  studies here showing defective NP-specific affinity maturation in <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice can only be interpreted to suggest that  affinity maturation within GCs has failed in these mice.</p><p>Recirculating memory B cells migrate between secondary  lymphoid organ follicles where they can respond to antigen  held on FDC networks (<xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B63">63</xref>). Marginal zone memory B  cells are said to be long-lived and non-recirculating (<xref ref-type="bibr" rid="B64">64</xref>&#x02013;<xref ref-type="bibr" rid="B66">66</xref>),  and it is difficult to conceive of how their maintenance could  be dependent on antigen retained by FDC networks. As the  name suggests, marginal zone memory B cells have been best  characterized in the marginal zone of the spleen, where they  are seen to appear both immediately before and during GC  reactions (<xref ref-type="bibr" rid="B63">63</xref>&#x02013;<xref ref-type="bibr" rid="B65">65</xref>). Equivalent areas are located on the inner  wall of the subcapsular sinus of LNs, and may be substantial  in MLNs (<xref ref-type="bibr" rid="B65">65</xref>). Further studies will be necessary to characterize the B cell memory in <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice, including how the nature and dose of antigen might affect memory maintenance  besides memory generation per se.</p><p>In conclusion, this study has considered GC reactions in  the MLNs of <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice and found that both GC and B  cell memory are formed despite the complete absence of  FDC networks. However, antigen-specific antibody affinity maturation is defective. This study of the MLNs of <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup>  mice serves as a model for the consequences of administration of soluble LT&#x003b2;R with respect to LNs. The spleen of  <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice was not studied here because it is more disorganized than the MLNs (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B30">30</xref>). The fact that anti-NP  memory at week 10 was much less apparent in serum than  in MLNs (Fig. <xref ref-type="fig" rid="F7">7</xref>) may well be a reflection of the fact that  serum antibody levels are dominated by the spleen and  spleen-derived bone marrow antibody-secreting cells. Having said this, even the spleen of <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice generates some  PNA-binding GC-like B cells (<xref ref-type="bibr" rid="B27">27</xref>).</p></sec></body><back><sec sec-type="display-objects"><title>Figures and Tables</title><fig position="float" id="F1"><label>Figure 1</label><caption><p><italic>Lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice generate GC B cell clusters without  FDCs. MLNs were from unchallenged 6&#x02013;8-wk-old wild-type  mice (A, C, and E) and <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup>  mice (B, D, and F) and show  GCs generated at random times  as a result of environmental antigens. Staining for IgD in all panels is brown. CD24 (A and B),  CD23 (C and D), and FDC-M2  (E and F) are purple-blue. The  intensely colored cells in D  (<italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup>) are B cells, which are  both IgD<sup>&#x0002b;</sup> and CD23<sup>&#x0002b;</sup>. This intense color is not as strong in C  (wild-type), presumably because  the intensely CD23<sup>hi</sup> FDCs have  &#x0201c;quenched&#x0201d; the color reaction  somewhat. Fluorocytometry did  not reveal any significant difference in CD23 levels between  wild-type and <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> MLN cells  (data not shown). Original magnification: &#x000d7;62.5.</p></caption><graphic xlink:href="JEM982113.f1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p>Fluorocytometry reveals GC B  cells in <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse MLNs. Most non-GC  B cells were excluded as Lin<sup>&#x0002b;</sup> cells (see text).  GC B cells were further identified with  PNA, CD24, and GL7. Plots shown are a  representative experiment using MLN 12 d  after intraperitoneal challenge with 50 &#x003bc;g  CG adsorbed to alum. The boxed areas include GC B cells, and the numbers alongside them indicate the percentage of the total MLN cells therein. WT, wild-type.</p></caption><graphic xlink:href="JEM982113.f2"/></fig><fig position="float" id="F3"><label>Figure 3</label><caption><p><italic>Lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice show antigen-specific B cell expansion in their MLNs.  MLNs were harvested at day 8 after challenge with 50 &#x003bc;g NP<sub>13</sub>CG adsorbed to  alum, and cells were examined for NP<sub>20</sub>PE-binding and surface &#x003bb;1 antibody chain. WT,  wild-type.</p></caption><graphic xlink:href="JEM982113.f3"/></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p><italic>Lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice generate antigen-specific GC B cells. Plots  show NP<sub>20</sub>PE-binding and surface &#x003bb;1 antibody chain among Lin<sup>&#x02212;</sup>GL7<sup>&#x0002b;</sup>  GC B cells from wild-type mouse MLNs (top) and <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse MLNs  (bottom) at day 8 after challenge with 50 &#x003bc;g NP<sub>13</sub>CG adsorbed to alum.</p></caption><graphic xlink:href="JEM982113.f4"/></fig><fig position="float" id="F5"><label>Figure 5</label><caption><p><italic>Lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> GC and non-GC antigen-specific MLN cells  decline rapidly. MLNs were harvested at various times after challenge with 50 &#x003bc;g NP<sub>13</sub>CG  adsorbed to alum. Antigen-specific  GC and non-GC cells were  defined as Lin<sup>&#x02212;</sup>GL7<sup>&#x0002b;</sup>&#x003bb;1<sup>&#x0002b;</sup> and  Lin<sup>&#x02212;</sup>GL7<sup>&#x02212;</sup>&#x003bb;1<sup>&#x0002b;</sup> cells, respectively.  Wild-type mouse MLN cells (circles) and <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mouse MLN cells  (triangles) are shown as both total  Lin<sup>&#x02212;</sup>&#x003bb;1<sup>&#x0002b;</sup> cells (filled symbols) and  as cells therein that also bound  NP<sub>20</sub>PE (open symbols). 4&#x02013;6 mice  were used per group and are represented as the average plus SD (8 of  38 <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice used for this study  did not appear to have MLNs).</p></caption><graphic xlink:href="JEM982113.f5"/></fig><fig position="float" id="F6"><label>Figure 6</label><caption><p><italic>Lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice generate reduced but significant antigen-specific antibody in their MLNs. MLNs were harvested from six wild-type  mice (circles) and <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice (triangles) at day 6 after challenge with 50 &#x003bc;g  NP<sub>13</sub>CG adsorbed to alum and were assayed for IgM (open symbols) and  IgG1 (filled symbols) using NP<sub>15</sub>BSA as the detection substrate. Data are  shown as relative units using IgG1 detection in the serum of a hyperimmunized wild-type mouse as a standard (see Materials and Methods).</p></caption><graphic xlink:href="JEM982113.f6"/></fig><fig position="float" id="F7"><label>Figure 7</label><caption><p><italic>Lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice generate humoral memory and show post-GC affinity maturation. Mice were harvested at both week 4 and week 10 after challenge with 50 &#x003bc;g NP<sub>13</sub>CG adsorbed to alum. Anti-NP antibody levels were followed in MLNs (top two rows) and serum (bottom two rows) using five  to seven wild-type mice (circles) and <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice (triangles) per group. Some groups were given a secondary challenge of 0.2 mg NP<sub>13</sub>CG in PBS alone  6 d before culling (filled symbols), while others were given just PBS (open symbols). Data are shown for both NP<sub>2</sub>BSA and NP<sub>15</sub>BSA as detection substrate (8 of 32 <italic>lt&#x003b2;</italic><sup>&#x02212;/&#x02212;</sup> mice used for this study did not appear to have MLNs). Anti-NP IgG1 relative units (&#x000d7;10<sup>&#x02212;5</sup>) represent the reciprocal of the standard  serum dilution giving the same OD<sub>405</sub> as the sample. Note that the MLN anti-NP IgG1 assays are not directly comparable with the serum assays. Also  shown are the resultant NP<sub>2</sub>/NP<sub>15</sub> ratios of the memory responses (filled symbols), which are a reflection of relative anti-NP affinity. Numbers alongside  various data points indicate overlapping mice, and bars represent averages.</p></caption><graphic xlink:href="JEM982113.f7"/></fig></sec><ack><p>We are indebted to Garnett Kelsoe for Ls136 antibody, Marie Kosco-Vilbois for FDC-M2 antibody, Frank  Wilson for technical assistance, Fran Manzo for clerical assistance, and Michiko Shimoda for invaluable  advice and discussion.</p><p>This study was supported by the American Diabetes Association and the Howard Hughes Medical Institute.  R.A. Flavell is an Investigator of the Howard Hughes Medical Institute.</p></ack><glossary><title>Abbreviations used in this paper</title><def-list><def-item><term>APC</term><def><p>allophycocyanin</p></def></def-item><def-item><term>CG</term><def><p>chicken  &#x003b3;-globulin</p></def></def-item><def-item><term>DIG</term><def><p>digoxigenin</p></def></def-item><def-item><term>FDC</term><def><p>follicular dendritic cell</p></def></def-item><def-item><term>GC</term><def><p>germinal  center</p></def></def-item><def-item><term>GCDC</term><def><p>GC dendritic cell</p></def></def-item><def-item><term>Lin</term><def><p>lineage</p></def></def-item><def-item><term>LT</term><def><p>lymphotoxin</p></def></def-item><def-item><term>MLN</term><def><p>mesenteric lymph node</p></def></def-item><def-item><term>NP</term><def><p>(4-hydroxy-3-nitrophenyl)acetyl</p></def></def-item><def-item><term>PNA</term><def><p>peanut agglutinin</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klaus</surname><given-names>GGB</given-names></name><name><surname>Humphrey</surname><given-names>JH</given-names></name><name><surname>Kunkl</surname><given-names>A</given-names></name><name><surname>Dongworth</surname><given-names>DW</given-names></name></person-group><article-title>The follicular dendritic cell: its role in antigen presentation in the generation of immunological memory</article-title><source>Immunol Rev</source><year>1980</year><volume>53</volume><fpage>3</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">7009406</pub-id></citation></ref><ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mandel</surname><given-names>TE</given-names></name><name><surname>Phipps</surname><given-names>RP</given-names></name><name><surname>Abbot</surname><given-names>A</given-names></name><name><surname>Tew</surname><given-names>JG</given-names></name></person-group><article-title>The follicular dendritic cell: long term antigen retention during immunity</article-title><source>Immunol Rev</source><year>1980</year><volume>53</volume><fpage>29</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">6162778</pub-id></citation></ref><ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schriever</surname><given-names>F</given-names></name><name><surname>Nadler</surname><given-names>LM</given-names></name></person-group><article-title>The central role of follicular dendritic cells in lymphoid tissues</article-title><source>Adv Immunol</source><year>1992</year><volume>51</volume><fpage>243</fpage><lpage>284</lpage><pub-id pub-id-type="pmid">1502976</pub-id></citation></ref><ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tew</surname><given-names>JG</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Qin</surname><given-names>D</given-names></name><name><surname>Helm</surname><given-names>S</given-names></name><name><surname>Burton</surname><given-names>GF</given-names></name><name><surname>Szakal</surname><given-names>AK</given-names></name></person-group><article-title>Follicular dendritic cells and presentation of antigen and costimulatory signals to B cells</article-title><source>Immunol Rev</source><year>1997</year><volume>156</volume><fpage>39</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">9176698</pub-id></citation></ref><ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schrager</surname><given-names>LK</given-names></name><name><surname>Fauci</surname><given-names>AS</given-names></name></person-group><article-title>Trapped but still dangerous</article-title><source>Nature</source><year>1995</year><volume>377</volume><fpage>680</fpage><lpage>681</lpage><pub-id pub-id-type="pmid">7477256</pub-id></citation></ref><ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heath</surname><given-names>SL</given-names></name><name><surname>Tew</surname><given-names>JG</given-names></name><name><surname>Tew</surname><given-names>JG</given-names></name><name><surname>Szakal</surname><given-names>AK</given-names></name><name><surname>Burton</surname><given-names>GF</given-names></name></person-group><article-title>Follicular dendritic cells and human immunodeficiency virus infectivity</article-title><source>Nature</source><year>1995</year><volume>377</volume><fpage>740</fpage><lpage>744</lpage><pub-id pub-id-type="pmid">7477265</pub-id></citation></ref><ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haase</surname><given-names>AT</given-names></name><name><surname>Henry</surname><given-names>K</given-names></name><name><surname>Zupancic</surname><given-names>M</given-names></name><name><surname>Sedgewick</surname><given-names>G</given-names></name><name><surname>Faust</surname><given-names>RA</given-names></name><name><surname>Melroe</surname><given-names>H</given-names></name><name><surname>Cavert</surname><given-names>W</given-names></name><name><surname>Gebhard</surname><given-names>K</given-names></name><name><surname>Staskus</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>ZQ</given-names></name><etal/></person-group><article-title>Quantitative image analysis of HIV-1 infection in lymphoid tissue</article-title><source>Science</source><year>1996</year><volume>274</volume><fpage>985</fpage><lpage>989</lpage><pub-id pub-id-type="pmid">8875941</pub-id></citation></ref><ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burton</surname><given-names>GF</given-names></name><name><surname>Masuda</surname><given-names>A</given-names></name><name><surname>Heath</surname><given-names>SL</given-names></name><name><surname>Smith</surname><given-names>BA</given-names></name><name><surname>Tew</surname><given-names>JG</given-names></name><name><surname>Szakal</surname><given-names>AK</given-names></name></person-group><article-title>Follicular dendritic cells (FDC) in retroviral infection: host/pathogen perspective</article-title><source>Immunol Rev</source><year>1997</year><volume>156</volume><fpage>185</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">9176708</pub-id></citation></ref><ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>MacLennan</surname><given-names>ICM</given-names></name></person-group><article-title>Germinal centers</article-title><source>Annu Rev Immunol</source><year>1994</year><volume>12</volume><fpage>117</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">8011279</pub-id></citation></ref><ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kelsoe</surname><given-names>G</given-names></name></person-group><article-title><italic>In situ</italic>studies of the germinal center reaction</article-title><source>Adv Immunol</source><year>1996</year><volume>60</volume><fpage>267</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">8607371</pub-id></citation></ref><ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rajewsky</surname><given-names>K</given-names></name></person-group><article-title>Clonal selection and learning in the antibody system</article-title><source>Nature</source><year>1996</year><volume>381</volume><fpage>751</fpage><lpage>758</lpage><pub-id pub-id-type="pmid">8657279</pub-id></citation></ref><ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kunkl</surname><given-names>A</given-names></name><name><surname>Klaus</surname><given-names>GGB</given-names></name></person-group><article-title>The generation of memory cells. I. Immunization with antigen-antibody complexes accelerates the development of B-memory cells, the formation of germinal centres and the maturation of antibody affinity in the secondary response</article-title><source>Immunology</source><year>1981</year><volume>43</volume><fpage>371</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">7019054</pub-id></citation></ref><ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindhout</surname><given-names>E</given-names></name><name><surname>Koopman</surname><given-names>G</given-names></name><name><surname>Pals</surname><given-names>ST</given-names></name><name><surname>de Groot</surname><given-names>C</given-names></name></person-group><article-title>Triple check for antigen specificity of B cells during germinal center reactions</article-title><source>Immunol Today</source><year>1997</year><volume>18</volume><fpage>573</fpage><lpage>577</lpage><pub-id pub-id-type="pmid">9425734</pub-id></citation></ref><ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Androlewicz</surname><given-names>MJ</given-names></name><name><surname>Browning</surname><given-names>JL</given-names></name><name><surname>Ware</surname><given-names>CF</given-names></name></person-group><article-title>Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma</article-title><source>J Biol Chem</source><year>1992</year><volume>267</volume><fpage>2542</fpage><lpage>2547</lpage><pub-id pub-id-type="pmid">1733951</pub-id></citation></ref><ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Browning</surname><given-names>JL</given-names></name><name><surname>Ngam-ek</surname><given-names>A</given-names></name><name><surname>Lawton</surname><given-names>P</given-names></name><name><surname>DeMarinis</surname><given-names>J</given-names></name><name><surname>Tizard</surname><given-names>R</given-names></name><name><surname>Chow</surname><given-names>EP</given-names></name><name><surname>Hession</surname><given-names>C</given-names></name><name><surname>O'Brine-Greco</surname><given-names>B</given-names></name><name><surname>Foley</surname><given-names>SF</given-names></name><name><surname>Ware</surname><given-names>CF</given-names></name></person-group><article-title>Lymphotoxin &#x003b2;, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface</article-title><source>Cell</source><year>1993</year><volume>72</volume><fpage>847</fpage><lpage>856</lpage><pub-id pub-id-type="pmid">7916655</pub-id></citation></ref><ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>NL</given-names></name><name><surname>Ruddle</surname><given-names>NH</given-names></name></person-group><article-title>Lymphotoxin</article-title><source>Annu  Rev Immunol</source><year>1988</year><volume>6</volume><fpage>407</fpage><lpage>438</lpage><pub-id pub-id-type="pmid">3289572</pub-id></citation></ref><ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ware</surname><given-names>CF</given-names></name><name><surname>VanArsdale</surname><given-names>TL</given-names></name><name><surname>Crowe</surname><given-names>PD</given-names></name><name><surname>Browning</surname><given-names>JL</given-names></name></person-group><article-title>The ligands and receptors of the lymphotoxin system</article-title><source>Curr Top Microbiol Immunol</source><year>1995</year><volume>198</volume><fpage>175</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">7774281</pub-id></citation></ref><ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hochman</surname><given-names>PS</given-names></name><name><surname>Majeau</surname><given-names>GR</given-names></name><name><surname>Mackay</surname><given-names>F</given-names></name><name><surname>Browning</surname><given-names>JL</given-names></name></person-group><article-title>Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin li&#x02013; gands</article-title><source>J Inflamm</source><year>1996</year><volume>46</volume><fpage>220</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">8878796</pub-id></citation></ref><ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Browning</surname><given-names>JL</given-names></name><name><surname>Miatkowski</surname><given-names>K</given-names></name><name><surname>Sizing</surname><given-names>I</given-names></name><name><surname>Griffiths</surname><given-names>D</given-names></name><name><surname>Zafari</surname><given-names>M</given-names></name><name><surname>Benjamin</surname><given-names>CD</given-names></name><name><surname>Meier</surname><given-names>W</given-names></name><name><surname>Mackay</surname><given-names>F</given-names></name></person-group><article-title>Signaling through the lymphotoxin &#x003b2; receptor induces the death of some adenocarcinoma tumor lines</article-title><source>J Exp Med</source><year>1996</year><volume>183</volume><fpage>867</fpage><lpage>878</lpage><pub-id pub-id-type="pmid">8642291</pub-id></citation></ref><ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>MacKay</surname><given-names>F</given-names></name><name><surname>Bourdon</surname><given-names>PR</given-names></name><name><surname>Griffiths</surname><given-names>DA</given-names></name><name><surname>Lawton</surname><given-names>P</given-names></name><name><surname>Zafari</surname><given-names>M</given-names></name><name><surname>Sizing</surname><given-names>ID</given-names></name><name><surname>Miatkowski</surname><given-names>K</given-names></name><name><surname>Ngam-ek</surname><given-names>A</given-names></name><name><surname>Benjamin</surname><given-names>CD</given-names></name><name><surname>Hession</surname><given-names>C</given-names></name><etal/></person-group><article-title>Cytotoxic activities of recombinant soluble murine lymphotoxin-&#x003b1; and lymphotoxin-&#x003b1;&#x003b2; complexes</article-title><source>J Immunol</source><year>1997</year><volume>159</volume><fpage>3299</fpage><lpage>3310</lpage><pub-id pub-id-type="pmid">9317128</pub-id></citation></ref><ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Degli-Esposti</surname><given-names>MA</given-names></name><name><surname>Davis-Smith</surname><given-names>T</given-names></name><name><surname>Din</surname><given-names>WS</given-names></name><name><surname>Smolak</surname><given-names>PJ</given-names></name><name><surname>Goodwin</surname><given-names>RG</given-names></name><name><surname>Smith</surname><given-names>CA</given-names></name></person-group><article-title>Activation of the lymphotoxin &#x003b2; receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells</article-title><source>J Immunol</source><year>1997</year><volume>158</volume><fpage>1756</fpage><lpage>1762</lpage><pub-id pub-id-type="pmid">9029113</pub-id></citation></ref><ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Togni</surname><given-names>P</given-names></name><name><surname>Goellner</surname><given-names>J</given-names></name><name><surname>Ruddle</surname><given-names>NH</given-names></name><name><surname>Streeter</surname><given-names>PR</given-names></name><name><surname>Fick</surname><given-names>A</given-names></name><name><surname>Mariathasan</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>SC</given-names></name><name><surname>Carlson</surname><given-names>R</given-names></name><name><surname>Shornick</surname><given-names>LP</given-names></name><name><surname>Strauss-Schoenberger</surname><given-names>J</given-names></name><etal/></person-group><article-title>Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin</article-title><source>Science</source><year>1994</year><volume>264</volume><fpage>703</fpage><lpage>707</lpage><pub-id pub-id-type="pmid">8171322</pub-id></citation></ref><ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Banks</surname><given-names>TA</given-names></name><name><surname>Rouse</surname><given-names>BT</given-names></name><name><surname>Kerley</surname><given-names>MK</given-names></name><name><surname>Blair</surname><given-names>PJ</given-names></name><name><surname>Godfrey</surname><given-names>VL</given-names></name><name><surname>Kuklin</surname><given-names>NA</given-names></name><name><surname>Bouley</surname><given-names>DM</given-names></name><name><surname>Thomas</surname><given-names>J</given-names></name><name><surname>Kanangat</surname><given-names>S</given-names></name><name><surname>Mucenski</surname><given-names>ML</given-names></name></person-group><article-title>Lymphotoxin-&#x003b1;-deficient mice: effects on secondary lymphoid organ development and humoral immune responsiveness</article-title><source>J Immunol</source><year>1995</year><volume>155</volume><fpage>1685</fpage><lpage>1693</lpage><pub-id pub-id-type="pmid">7636227</pub-id></citation></ref><ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Lo</surname><given-names>SF</given-names></name><name><surname>Carruthers</surname><given-names>CJL</given-names></name><name><surname>Min</surname><given-names>J</given-names></name><name><surname>Mariathasan</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Plas</surname><given-names>DR</given-names></name><name><surname>Martin</surname><given-names>SM</given-names></name><name><surname>Geha</surname><given-names>RS</given-names></name><name><surname>Nahm</surname><given-names>MH</given-names></name><name><surname>Chaplin</surname><given-names>DD</given-names></name></person-group><article-title>Affinity maturation without germinal centers in lymphotoxin-&#x003b1;-deficient mice</article-title><source>Nature</source><year>1996</year><volume>382</volume><fpage>462</fpage><lpage>466</lpage><pub-id pub-id-type="pmid">8684487</pub-id></citation></ref><ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Mariathasan</surname><given-names>S</given-names></name><name><surname>Nahm</surname><given-names>MH</given-names></name><name><surname>Baranyay</surname><given-names>F</given-names></name><name><surname>Peschon</surname><given-names>JJ</given-names></name><name><surname>Chaplin</surname><given-names>DD</given-names></name></person-group><article-title>Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers</article-title><source>Science</source><year>1996</year><volume>271</volume><fpage>1289</fpage><lpage>1291</lpage><pub-id pub-id-type="pmid">8638112</pub-id></citation></ref><ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koni</surname><given-names>PA</given-names></name><name><surname>Sacca</surname><given-names>R</given-names></name><name><surname>Lawton</surname><given-names>P</given-names></name><name><surname>Browning</surname><given-names>JL</given-names></name><name><surname>Ruddle</surname><given-names>NH</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name></person-group><article-title>Distinct roles in lymphoid organogenesis for lymphotoxins &#x003b1; and &#x003b2; revealed in lymphotoxin &#x003b2;-deficient mice</article-title><source>Immunity</source><year>1997</year><volume>6</volume><fpage>491</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">9133428</pub-id></citation></ref><ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alimzhanov</surname><given-names>MB</given-names></name><name><surname>Kuprash</surname><given-names>DV</given-names></name><name><surname>Kosco-Vilbois</surname><given-names>MH</given-names></name><name><surname>Luz</surname><given-names>A</given-names></name><name><surname>Turetskaya</surname><given-names>RL</given-names></name><name><surname>Tarakhovsky</surname><given-names>A</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name><name><surname>Nedospasov</surname><given-names>SA</given-names></name><name><surname>Pfeffer</surname><given-names>K</given-names></name></person-group><article-title>Abnormal development of secondary lymphoid tissues in lymphotoxin &#x003b2;-deficient mice</article-title><source>Proc Natl Acad Sci USA</source><year>1997</year><volume>94</volume><fpage>9302</fpage><lpage>9307</lpage><pub-id pub-id-type="pmid">9256477</pub-id></citation></ref><ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>F&#x000fc;tterer</surname><given-names>A</given-names></name><name><surname>Mink</surname><given-names>K</given-names></name><name><surname>Luz</surname><given-names>A</given-names></name><name><surname>Kosco-Vilbois</surname><given-names>MH</given-names></name><name><surname>Pfeffer</surname><given-names>K</given-names></name></person-group><article-title>The lymphotoxin &#x003b2; receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues</article-title><source>Immunity</source><year>1998</year><volume>9</volume><fpage>59</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">9697836</pub-id></citation></ref><ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alexopoulou</surname><given-names>L</given-names></name><name><surname>Pasparakis</surname><given-names>M</given-names></name><name><surname>Kollias</surname><given-names>G</given-names></name></person-group><article-title>Complementation of lymphotoxin &#x003b1; knockout mice with tumor necrosis factor&#x02013;expressing transgenes rectifies defective splenic structure and function</article-title><source>J Exp Med</source><year>1998</year><volume>188</volume><fpage>745</fpage><lpage>754</lpage><pub-id pub-id-type="pmid">9705956</pub-id></citation></ref><ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koni</surname><given-names>PA</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name></person-group><article-title>A role for tumor necrosis factor receptor type 1 in gut-associated lymphoid tissue development: genetic evidence of synergism with lymphotoxin &#x003b2;</article-title><source>J Exp Med</source><year>1998</year><volume>187</volume><fpage>1977</fpage><lpage>1983</lpage><pub-id pub-id-type="pmid">9625757</pub-id></citation></ref><ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grouard</surname><given-names>G</given-names></name><name><surname>Durand</surname><given-names>I</given-names></name><name><surname>Filgueira</surname><given-names>L</given-names></name><name><surname>Banchereau</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>Y-J</given-names></name></person-group><article-title>Dendritic cells capable of stimulating T cells in germinal centers</article-title><source>Nature</source><year>1996</year><volume>384</volume><fpage>364</fpage><lpage>367</lpage><pub-id pub-id-type="pmid">8934523</pub-id></citation></ref><ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kroese</surname><given-names>FGM</given-names></name><name><surname>Wubbena</surname><given-names>AS</given-names></name><name><surname>Nieuwenhuis</surname><given-names>P</given-names></name></person-group><article-title>Germinal centre formation and follicular antigen trapping in the spleen of lethally X-irradiated and reconstituted rats</article-title><source>Immunology</source><year>1986</year><volume>57</volume><fpage>99</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">3510969</pub-id></citation></ref><ref id="B33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>MacKay</surname><given-names>F</given-names></name><name><surname>Browning</surname><given-names>JL</given-names></name></person-group><article-title>Turning off follicular dendritic cells</article-title><source>Nature</source><year>1998</year><volume>395</volume><fpage>26</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">9738494</pub-id></citation></ref><ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>J</given-names></name><name><surname>Motoyama</surname><given-names>N</given-names></name><name><surname>Taniuchi</surname><given-names>I</given-names></name><name><surname>Takeshita</surname><given-names>H</given-names></name><name><surname>Toyoda</surname><given-names>M</given-names></name><name><surname>Masuda</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name></person-group><article-title>Affinity maturation in Lyn kinase-deficient mice with defective germinal center formation</article-title><source>J Immunol</source><year>1998</year><volume>160</volume><fpage>4788</fpage><lpage>4795</lpage><pub-id pub-id-type="pmid">9590225</pub-id></citation></ref><ref id="B35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Foy</surname><given-names>TM</given-names></name><name><surname>Laman</surname><given-names>JD</given-names></name><name><surname>Elliott</surname><given-names>EA</given-names></name><name><surname>Dunn</surname><given-names>JJ</given-names></name><name><surname>Waldschmidt</surname><given-names>TJ</given-names></name><name><surname>Elsemore</surname><given-names>J</given-names></name><name><surname>Noelle</surname><given-names>RJ</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name></person-group><article-title>Mice deficient for the CD40 ligand</article-title><source>Immunity</source><year>1994</year><volume>1</volume><fpage>423</fpage><lpage>431</lpage><pub-id pub-id-type="pmid">7882172</pub-id></citation></ref><ref id="B36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>BS</given-names></name><name><surname>Levy</surname><given-names>JG</given-names></name><name><surname>Sikora</surname><given-names>L</given-names></name></person-group><article-title>The use of enzyme-linked immunosorbent assay (ELISA) for the detection and quantification of specific antibody from cell cultures</article-title><source>Immunology</source><year>1979</year><volume>37</volume><fpage>45</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">381177</pub-id></citation></ref><ref id="B37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>ML</given-names></name><name><surname>Birbeck</surname><given-names>MSC</given-names></name><name><surname>Wallis</surname><given-names>VJ</given-names></name><name><surname>Forrester</surname><given-names>JA</given-names></name><name><surname>Davies</surname><given-names>AJS</given-names></name></person-group><article-title>Peanut lectin binding properties of germinal centers of mouse lymphoid tissue</article-title><source>Nature</source><year>1980</year><volume>284</volume><fpage>364</fpage><lpage>366</lpage><pub-id pub-id-type="pmid">7360273</pub-id></citation></ref><ref id="B38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>RR</given-names></name><name><surname>Hayakawa</surname><given-names>K</given-names></name><name><surname>Parks</surname><given-names>DR</given-names></name><name><surname>Herzenberg</surname><given-names>LA</given-names></name><name><surname>Herzenberg</surname><given-names>LA</given-names></name></person-group><article-title>Murine B cell differentiation lineages</article-title><source>J Exp Med</source><year>1984</year><volume>159</volume><fpage>1169</fpage><lpage>1188</lpage><pub-id pub-id-type="pmid">6423764</pub-id></citation></ref><ref id="B39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lalor</surname><given-names>PA</given-names></name><name><surname>Nossal</surname><given-names>GJV</given-names></name><name><surname>Sanderson</surname><given-names>RD</given-names></name><name><surname>McHeyzer-Williams</surname><given-names>MG</given-names></name></person-group><article-title>Functional and molecular characterization of single, (4-hydroxy-3-nitrophenyl)acetyl (NP)- specific, IgG<sub>1</sub><sup>&#x0002b;</sup>B cells from antibody-secreting and memory B cell pathways in C57BL/6 immune response to NP</article-title><source>Eur J  Immunol</source><year>1992</year><volume>22</volume><fpage>3001</fpage><lpage>3011</lpage><pub-id pub-id-type="pmid">1425924</pub-id></citation></ref><ref id="B40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kimoto</surname><given-names>H</given-names></name><name><surname>Nagaoka</surname><given-names>H</given-names></name><name><surname>Adachi</surname><given-names>Y</given-names></name><name><surname>Mizuochi</surname><given-names>T</given-names></name><name><surname>Azuma</surname><given-names>T</given-names></name><name><surname>Yagi</surname><given-names>T</given-names></name><name><surname>Sata</surname><given-names>T</given-names></name><name><surname>Yonehara</surname><given-names>S</given-names></name><name><surname>Tsunetsugu-Yokota</surname><given-names>Y</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Takemori</surname><given-names>T</given-names></name></person-group><article-title>Accumulation of somatic hypermutation and antigen-driven selection  in rapidly-cycling surface Ig<sup>&#x0002b;</sup>germinal center (GC) B cells which occupy GC at a high frequency during primary anti-hapten response in mice</article-title><source>Eur J Immunol</source><year>1997</year><volume>27</volume><fpage>268</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">9022029</pub-id></citation></ref><ref id="B41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahearn</surname><given-names>JM</given-names></name><name><surname>Fischer</surname><given-names>MB</given-names></name><name><surname>Croix</surname><given-names>D</given-names></name><name><surname>Goerg</surname><given-names>S</given-names></name><name><surname>Ma</surname><given-names>M</given-names></name><name><surname>Xia</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Howard</surname><given-names>RG</given-names></name><name><surname>Rothstein</surname><given-names>TL</given-names></name><name><surname>Carroll</surname><given-names>MC</given-names></name></person-group><article-title>Disruption of the <italic>Cr2</italic>locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen</article-title><source>Immunity</source><year>1996</year><volume>4</volume><fpage>251</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">8624815</pub-id></citation></ref><ref id="B42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Molina</surname><given-names>H</given-names></name><name><surname>Holers</surname><given-names>VM</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Fang</surname><given-names>Y-F</given-names></name><name><surname>Mariathasan</surname><given-names>S</given-names></name><name><surname>Goellner</surname><given-names>J</given-names></name><name><surname>Strauss-Schoenberger</surname><given-names>J</given-names></name><name><surname>Karr</surname><given-names>RW</given-names></name><name><surname>Chaplin</surname><given-names>DD</given-names></name></person-group><article-title>Markedly impaired humoral response in mice deficient in complement receptors 1 and 2</article-title><source>Proc Natl Acad  Sci USA</source><year>1996</year><volume>93</volume><fpage>3357</fpage><lpage>3361</lpage><pub-id pub-id-type="pmid">8622941</pub-id></citation></ref><ref id="B43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maeda</surname><given-names>K</given-names></name><name><surname>Burton</surname><given-names>GF</given-names></name><name><surname>Padgett</surname><given-names>DA</given-names></name><name><surname>Conrad</surname><given-names>DH</given-names></name><name><surname>Huff</surname><given-names>TF</given-names></name><name><surname>Masuda</surname><given-names>A</given-names></name><name><surname>Szakal</surname><given-names>A</given-names></name><name><surname>Tew</surname><given-names>JG</given-names></name></person-group><article-title>Murine follicular dendritic cells (FDC) and low affinity Fc-receptors for IgE (Fc&#x003b5;RII)</article-title><source>J Immunol</source><year>1992</year><volume>148</volume><fpage>2340</fpage><lpage>2347</lpage><pub-id pub-id-type="pmid">1532811</pub-id></citation></ref><ref id="B44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>S</given-names></name><name><surname>Dillon</surname><given-names>SR</given-names></name><name><surname>Zheng</surname><given-names>B</given-names></name><name><surname>Shimoda</surname><given-names>M</given-names></name><name><surname>Schlissel</surname><given-names>MS</given-names></name><name><surname>Kelsoe</surname><given-names>G</given-names></name></person-group><article-title>V(D)J recombinase activity in a subset of germinal center B lymphocytes</article-title><source>Science</source><year>1997</year><volume>278</volume><fpage>301</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">9323211</pub-id></citation></ref><ref id="B45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Dutta</surname><given-names>PR</given-names></name><name><surname>Cerasoli</surname><given-names>DM</given-names></name><name><surname>Kelsoe</surname><given-names>G</given-names></name></person-group><article-title>In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. V. Affinity maturation develops in two stages of clonal selection</article-title><source>J Exp Med</source><year>1998</year><volume>187</volume><fpage>885</fpage><lpage>895</lpage><pub-id pub-id-type="pmid">9500791</pub-id></citation></ref><ref id="B46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>J</given-names></name><name><surname>Kassir</surname><given-names>R</given-names></name><name><surname>Kelsoe</surname><given-names>G</given-names></name></person-group><article-title>In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl) acetyl. I. The architecture and dynamics of responding cell populations</article-title><source>J Exp Med</source><year>1991</year><volume>173</volume><fpage>1165</fpage><lpage>1175</lpage><pub-id pub-id-type="pmid">1902502</pub-id></citation></ref><ref id="B47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>J</given-names></name><name><surname>Kelsoe</surname><given-names>G</given-names></name></person-group><article-title>In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. II. A common clonal origin for periarteriolar lymphoid sheath&#x02013; associated foci and germinal centers</article-title><source>J Exp Med</source><year>1992</year><volume>176</volume><fpage>679</fpage><lpage>687</lpage><pub-id pub-id-type="pmid">1512536</pub-id></citation></ref><ref id="B48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>J</given-names></name><name><surname>Przylepa</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>C</given-names></name><name><surname>Kelsoe</surname><given-names>G</given-names></name></person-group><article-title>In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells</article-title><source>J Exp Med</source><year>1993</year><volume>178</volume><fpage>1293</fpage><lpage>1307</lpage><pub-id pub-id-type="pmid">8376935</pub-id></citation></ref><ref id="B49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jack</surname><given-names>RS</given-names></name><name><surname>Imanishi-Kari</surname><given-names>T</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name></person-group><article-title>Idiotypic analysis of the response of C57BL/6 mice to the (4-hydroxy-3-nitrophenyl)acetyl group</article-title><source>Eur J Immunol</source><year>1977</year><volume>8</volume><fpage>559</fpage><lpage>565</lpage><pub-id pub-id-type="pmid">409605</pub-id></citation></ref><ref id="B50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Makela</surname><given-names>O</given-names></name><name><surname>Karjalainen</surname><given-names>K</given-names></name></person-group><article-title>Inherited immunoglobulin idiotypes of the mouse</article-title><source>Immunol Rev</source><year>1977</year><volume>34</volume><fpage>119</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">66781</pub-id></citation></ref><ref id="B51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reth</surname><given-names>M</given-names></name><name><surname>Imanishi-Kari</surname><given-names>T</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name></person-group><article-title>Analysis of the repertoire of anti-NP antibodies in C57BL/6 mice by cell fusion. II. Characterization of idiotopes by monoclonal anti-idiotope antibodies</article-title><source>Eur J Immunol</source><year>1979</year><volume>9</volume><fpage>1004</fpage><lpage>1013</lpage><pub-id pub-id-type="pmid">398773</pub-id></citation></ref><ref id="B52"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cumano</surname><given-names>A</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name></person-group><article-title>Structure of primary anti-(4-hydroxy-3-nitrophenyl)acetyl (NP) antibodies in normal and idiotypically suppressed C57BL/6 mice</article-title><source>Eur J Immunol</source><year>1985</year><volume>15</volume><fpage>512</fpage><lpage>520</lpage><pub-id pub-id-type="pmid">3873342</pub-id></citation></ref><ref id="B53"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Fu</surname><given-names>Y-X</given-names></name><name><surname>Molina</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Thomas</surname><given-names>DA</given-names></name><name><surname>Nahm</surname><given-names>MH</given-names></name><name><surname>Chaplin</surname><given-names>DD</given-names></name></person-group><article-title>Distinct roles of lymphotoxin &#x003b1; and type I tumor necrosis factor (TNF) receptor in the establishment of follicular dendritic cells from non-bone marrow&#x02013;derived cells</article-title><source>J Exp Med</source><year>1997</year><volume>186</volume><fpage>1997</fpage><lpage>2004</lpage><pub-id pub-id-type="pmid">9396768</pub-id></citation></ref><ref id="B54"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maeda</surname><given-names>K</given-names></name><name><surname>Matsuda</surname><given-names>M</given-names></name><name><surname>Imai</surname><given-names>Y</given-names></name></person-group><article-title>Follicular dendritic cells: structure as related to function</article-title><source>Curr Top Microbiol Immunol</source><year>1995</year><volume>201</volume><fpage>119</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">7587347</pub-id></citation></ref><ref id="B55"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kapasi</surname><given-names>ZF</given-names></name><name><surname>Qin</surname><given-names>D</given-names></name><name><surname>Kerr</surname><given-names>WG</given-names></name><name><surname>Kosco-Vilbois</surname><given-names>MH</given-names></name><name><surname>Shultz</surname><given-names>LD</given-names></name><name><surname>Tew</surname><given-names>JG</given-names></name><name><surname>Szakal</surname><given-names>AK</given-names></name></person-group><article-title>Follicular dendritic cell (FDC) precursors in primary lymphoid tissues</article-title><source>J Immunol</source><year>1998</year><volume>160</volume><fpage>1078</fpage><lpage>1084</lpage><pub-id pub-id-type="pmid">9570519</pub-id></citation></ref><ref id="B56"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kosco-Vilbois</surname><given-names>MH</given-names></name><name><surname>Zentgraf</surname><given-names>H</given-names></name><name><surname>Gerdes</surname><given-names>J</given-names></name><name><surname>Bonnefoy</surname><given-names>J-Y</given-names></name></person-group><article-title>To &#x02018;B' or not to &#x02018;B' a germinal center? </article-title><source>Immunol  Today</source><year>1997</year><volume>18</volume><fpage>225</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">9153954</pub-id></citation></ref><ref id="B57"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>U</given-names></name><name><surname>Zoebelin</surname><given-names>R</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name></person-group><article-title>Accumulation of somatic mutants in the B cell compartment after primary immunization with a T cell-dependent antigen</article-title><source>Eur J  Immunol</source><year>1992</year><volume>22</volume><fpage>511</fpage><lpage>517</lpage><pub-id pub-id-type="pmid">1537385</pub-id></citation></ref><ref id="B58"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McHeyzer-Williams</surname><given-names>MG</given-names></name><name><surname>McLean</surname><given-names>MJ</given-names></name><name><surname>Lalor</surname><given-names>PA</given-names></name><name><surname>Nossal</surname><given-names>GJV</given-names></name></person-group><article-title>Antigen-driven B cell differentiation in vivo</article-title><source>J Exp Med</source><year>1993</year><volume>178</volume><fpage>295</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">8315385</pub-id></citation></ref><ref id="B59"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Casson</surname><given-names>LP</given-names></name><name><surname>Manser</surname><given-names>T</given-names></name></person-group><article-title>Random mutagenesis of two complementarity determining region amino acids yields an unexpectedly high frequency of antibodies with increased affinity for both cognate antigen and autoantigen</article-title><source>J Exp  Med</source><year>1995</year><volume>182</volume><fpage>743</fpage><lpage>750</lpage><pub-id pub-id-type="pmid">7650481</pub-id></citation></ref><ref id="B60"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bothwell</surname><given-names>ALM</given-names></name><name><surname>Paskind</surname><given-names>M</given-names></name><name><surname>Reth</surname><given-names>M</given-names></name><name><surname>Imanishi-Kari</surname><given-names>T</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name></person-group><article-title>Heavy chain variable  region contribution to the NP<sup>b</sup>family of antibodies: somatic mutation evident in a &#x003b3;2a variable region</article-title><source>Cell</source><year>1981</year><volume>24</volume><fpage>625</fpage><lpage>637</lpage><pub-id pub-id-type="pmid">6788376</pub-id></citation></ref><ref id="B61"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>D</given-names></name><name><surname>Simon</surname><given-names>T</given-names></name><name><surname>Sablitzky</surname><given-names>F</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name><name><surname>Cumano</surname><given-names>A</given-names></name></person-group><article-title>Antibody engineering for the analysis of affinity maturation of an anti-hapten response</article-title><source>EMBO (Eur Mol  Biol Organ) J</source><year>1988</year><volume>7</volume><fpage>1995</fpage><lpage>2000</lpage><pub-id pub-id-type="pmid">3138111</pub-id></citation></ref><ref id="B62"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>D</given-names></name><name><surname>Leanderson</surname><given-names>T</given-names></name></person-group><article-title>Expansion, selection and maintenance of memory B-cell clones</article-title><source>Curr Top Microbiol  Immunol</source><year>1990</year><volume>159</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">2189690</pub-id></citation></ref><ref id="B63"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>MacLennan</surname><given-names>ICM</given-names></name><name><surname>Liu</surname><given-names>YJ</given-names></name><name><surname>Oldfield</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Lane</surname><given-names>PJL</given-names></name></person-group><article-title>The evolution of B-cell clones</article-title><source>Curr Top  Microbiol Immunol</source><year>1990</year><volume>159</volume><fpage>37</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">2189692</pub-id></citation></ref><ref id="B64"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y-J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Lane</surname><given-names>PJL</given-names></name><name><surname>Chan</surname><given-names>EY-T</given-names></name><name><surname>MacLennan</surname><given-names>ICM</given-names></name></person-group><article-title>Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens</article-title><source>Eur J Immunol</source><year>1991</year><volume>21</volume><fpage>2951</fpage><lpage>2962</lpage><pub-id pub-id-type="pmid">1748148</pub-id></citation></ref><ref id="B65"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>MacLennan</surname><given-names>ICM</given-names></name><name><surname>Gulbranson-Judge</surname><given-names>A</given-names></name><name><surname>Toellner</surname><given-names>K-M</given-names></name><name><surname>Casamayor-Palleja</surname><given-names>M</given-names></name><name><surname>Chan</surname><given-names>E</given-names></name><name><surname>Sze</surname><given-names>DM-Y</given-names></name><name><surname>Luther</surname><given-names>SA</given-names></name><name><surname>Orbea</surname><given-names>HA</given-names></name></person-group><article-title>The changing preference of T and B cells for partners as T-dependent antibody responses develop</article-title><source>Immunol Rev</source><year>1997</year><volume>156</volume><fpage>53</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">9176699</pub-id></citation></ref><ref id="B66"><label>66</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y-J</given-names></name></person-group><article-title>Sites of B lymphocyte selection, activation, and tolerance in spleen</article-title><source>J Exp Med</source><year>1997</year><volume>186</volume><fpage>625</fpage><lpage>629</lpage><pub-id pub-id-type="pmid">9312553</pub-id></citation></ref></ref-list></back></article>


